Three outstanding early-career investigators have been selected as recipients of the 2016 SYNERGY Scholars Mentored Career Development Award, funded through Dartmouth SYNERGY Clinical and Translational Science Institute.
Dartmouth SYNERGY Scholars is an ongoing Mentored Career Development Program, modeled on the NIH KL2 Scholars Program. SYNERGY Scholars Program aims to develop early-career investigators involved in clinical and translational research by combining didactic training, mentoring, exposure to multidisciplinary research, and ongoing evaluation to prepare junior investigators for careers in Clinical and Translational Research.
The selected scholars are chosen by a panel of senior scientists through a rigorous peer-review process. Each award involves two or more mentors who will collaborate with the scholar and oversee her/his progress in patient-oriented research; the mentors chosen reflect the disciplines needed to gain independence in the proposed area of research.
Congratulations to the following recipients of this highly competitive career development award!
Joshua Aronson, MD, Asst. Professor of Surgery
Project Title: Mechanisms of Learning and Recovery in a Mouse Traumatic Brain Injury Model
Mentor: Jeffrey Taube, PhD, Professor, Department of Psychological and Brain Sciences
Mentor: Emad Eskandar, MD, Charles Anthony Pappas Professor of Neuroscience, Harvard Medical School; Director of Functional Neurosurgery, Massachusetts General Hospital
Wilder Doucette, MD, PhD, Asst. Professor of Psychiatry
Project Title: Using a Rat Model to Assess the Translational Potential of Neuromodulation for Binge Eating: Towards Improved Obesity Outcomes
Mentor: Alan I. Green, MD, Raymond Sobel Professor of Psychiatry; Professor of Pharmacology and Toxicology; Chairman, Department of Psychiatry; Director, Dartmouth SYNERGY Clinical and Translational Science Institute
Mentor: Paul Holtzheimer, MD, Associate Professor of Psychiatry and Surgery; Director, Mood Disorders Service
Rodwell Mabaera, MD, PhD, Asst. Professor of Medicine
Project Title: Pilot Trial Examining Myeloid-Derived Suppressor Cells and Immune Checkpoint Regulator Expression in Allogeneic Stem Cell Transplant Recipients Using Myeloablative Busulfan and Fludarabine
Mentor: Kenneth Meehan, MD, Professor of Medicine; Director, Blood and Marrow Transplant Program
Mentor: Randolph Noelle, PhD, Professor of Microbiology and Immunology
The SYNERGY KL2 Scholars Program is supported by the Dartmouth Clinical and Translational Science Institute, under award number KL2TR001088, from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH).
More information: https://synergy.dartmouth.edu/synergy-scholars
